|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Production Systems
Automatic Future
Christopher Procyshyn at Vanrx Pharmasystems Inc looks at high mix, low volume manufacturing of aseptic parenteral dosages, and considers how robotic applications may lead to a more effective production cycle.
|
|
|
|
Construction & Technology
Setting the Scene
The first instalment of a two-part article sees Tim Sandle at Bio Products Laboratory and Madhu Raju Saghee atGland Pharma discuss the structure and air management of cleanrooms for pharmaceutical production, giving insight into the best process for their construction. |
|
|
|
Air Filtration
On Air
Rob Flaherty at Trion looks at the fan filter unit (FFU) – an important technology for effective cleanroom filtration – and points out the need for more energy-efficient FFUs in the face of higher environmental standards. |
|
|
|
Contamination Assessment
Need for Speed
Rapid microbial methods are showing themselves to be the superior form of contamination assessment in pharmaceutical product manufacturing. Cindy Lieberman at Celsis International Ltd highlights the timeline benefits that these techniques provide. |
|
|
|
Device Manufacturing and Production
The Whole Proof
A thorough and well-designed proof-of-principle test for pharmaceutical manufacturing machinery can ensure longterm equipment performance, and avoids undesirable labour and expensive remedial action, concludes Tobias Zill at Sortimat, an ATS affiliate. |
|
|
|
Automation and Robotics
Fixed Agenda
Peter Cavallo at DENSO Sales California presents the benefits of small assembly robots, which offer a level of adaptability above and beyond that of fixed solutions, allowing manufacturers to cut costs and enjoy a more flexible workflow. |
|
|
|
Device Manufacturing
The Right Idea
The skills and experience required to create a high level inhalation device are extensive, and the search for the right partner must be undertaken with several requirements in mind, explains Louise Righton at 3M Drug Delivery Systems. |
|
|
|
|
|
Cool Chain
Monitoring Value
The special treatment required by parenteral products creates a significant challenge for the cold chain management company. Olivier Simonnot at Sensitech Inc identifies factors that can assist the process, including good warehousing practice. |
|
|
|
Temperature-Controlled
Packaging Simplicity Rules
Andrew J Mills at Intelsius analyses the changing trends in drug development and how these will affect the logistics process, resulting in packaging that is tailored to smaller volume but higher value products. |
|
|
|
|
|
Delivery Devices
Health and Safety
Ludwig Weibel at Treff AG explores patient requirements for parenteral drugs, and considers how a user-friendly approach can influence the specification for the ideal reconstitution device. |
|
|
|
Controlled Release Technology
Sphere of Influence
An expansion in the market for extended release products is expected in the near future, with technologies such as biodegradable PLGA-based microspheres playing a considerable role. Márcio Temtem and José Luís Santos at Hovione SA describe the key characteristics of this delivery platform.
|
|
|
|
|
|
|
Injectable Drug Delivery Systems
Eye on the Needle
The growing demand for advances in fully automatic needle handling systems is leading to real progress in injectable drug delivery device design, as Thomas Jakob at RAUMEDIC AG explains. |
|
|
|
|
|
Coding and Labelling
The Elephant in the Room
Several problems with the management of serialisation data have come to the fore recently but, as Magnar Loken at Kezzler AS explains, delivering a system that can combine zero latency, high-volume data management and quick query response times may provide a solution. |
|
|
|
Primary Packaging
Material World
Stephen J Duckworth at Clariant International gives a breakdown of material change in primary packaging, and looks at the effect of extractables and leachables, while balancing the need for packaging to branch out in a competitive market. |
|
|
|
|
Powder Processing
Site Secrets
Paul Stanway of Powder Systems Ltd discusses how strong powder processing systems are enabling API manufacturing to become more powerful and streamlined, with reference to pertinent realworld applications. |
|
|
|
Dosage Forms
Smarter Particle Sizing
As Carl Levoguer at Malvern Instruments shows, the latest particle sizing systems offer ideal resolution levels across broad measurement ranges, effi cient dry dispersion and a small footprint, enabling a higher level of particle assessment than ever before. |
|
|
|
Dehydration Technology
High and Dry
Parastoo Yaghmaee at EnWave Corporation presents an alternative to lyophilisation that promises to handle larger dehydration projects in shorter timeframes, cutting manufacturing costs in the process. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing
GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >> |
|
 |
White Papers |
 |
|
Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody
RSSL
Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC India
26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India
As the pharma industry looks increasingly towards India for high quality,
low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies
wanting to pick up on the latest trends and innovations the market has to
offer. At CPhI & P-MEC India, you will meet the movers and shakers from
India's pharma machinery, technology and ingredients industries, giving you a
competitive advantage that will help grow your business.
More info >> |
|
|
